SCHEMBL13587294

SCHEMBL13587294

CNS(=O)(=O)N1CCSc2ccc(OC)cc2C1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
RYR2 Q92736 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6866692 0.85 RYR2 (1.00) RYR2
SCHEMBL13632613 0.85 RYR2 (0.80) RYR2
SCHEMBL12265394 0.84 RYR2 (0.77) RYR2
SCHEMBL6867956 0.84 RYR2 (0.78) RYR2
SCHEMBL12265368 0.83 RYR2 (0.81) RYR2
SCHEMBL6867436 0.81 RYR2 (0.73) RYR2
SCHEMBL8244596 0.81 RYR2 (0.73) RYR2
SCHEMBL12265304 0.80 RYR2 (0.77) RYR2
SCHEMBL6867272 0.79 RYR2 (1.00) RYR2
SCHEMBL6866695 0.79 RYR2 (1.00) RYR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2127654-A1 Benzothiazepine derivatives as ryanodine receptor (RYR2) inhibitors and their use in the treatment of cardiac diseases The Trustees of Columbia University in the City of New York (US) 2009-12-02 EP disclosed